Filter Results:
(8,680)
Show Results For
- All HBS Web
(8,680)
- People (19)
- News (1,764)
- Research (5,614)
- Events (40)
- Multimedia (110)
- Faculty Publications (3,842)
Show Results For
- All HBS Web
(8,680)
- People (19)
- News (1,764)
- Research (5,614)
- Events (40)
- Multimedia (110)
- Faculty Publications (3,842)
- October 1997
- Article
Does Competition Kill Corruption?
By: Christopher Bliss and Rafael Di Tella
Corrupt agents (officials or gangsters) exact money from firms. Corruption affects the number of firms in a free-entry equilibrium. The degree of deep competition in the economy increases with lower overhead costs relative to profits and with a tendency toward similar... View Details
Bliss, Christopher, and Rafael Di Tella. "Does Competition Kill Corruption?" Journal of Political Economy 105, no. 5 (October 1997): 1001–1023.
- 31 Mar 2020
- News
How To Recover Gracefully After Shutting Down Your Startup
- 10 Oct 2013
- Working Paper Summaries
Managing Churn to Maximize Profits
- 25 Jan 2012
- Research & Ideas
A Few Firms Have Outsized Influence in D.C.
researchers determined that all of the findings can be explained in part by high fixed costs to enter the lobbying club—both in the costs of... View Details
Keywords: by Michael Blanding
- February 1986 (Revised November 1992)
- Case
Novo Industri A/S--1981
By: W. Carl Kester and Glynn Ferguson
This small but rapidly growing Danish biochemical company must choose among several financing opportunities that include a convertible Eurobond, a rights offering in Denmark and an issue of new common shares in the United States. The case involves a broad range of... View Details
Keywords: Capital Markets; Cost of Capital; Bonds; Stock Shares; Financing and Loans; Globalization; Biotechnology Industry; Chemical Industry; Denmark; United States
Kester, W. Carl, and Glynn Ferguson. "Novo Industri A/S--1981." Harvard Business School Case 286-084, February 1986. (Revised November 1992.)
- November 1984 (Revised March 1999)
- Case
Mayers Tap, Inc. (A)
Mayers Tap, Inc. has a poorly designed cost accounting system and is in the process of redesigning it. This case provides background details for the rest of the Mayers Tap, Inc. series. View Details
Keywords: Management Systems
Cooper, Robin. "Mayers Tap, Inc. (A)." Harvard Business School Case 185-024, November 1984. (Revised March 1999.)
- 07 Dec 2017
- News
Innovation is key to solving America's health-care problems
- May 2009
- Article
Lobbies and Technology Diffusion
By: Diego Comin and Bart Hobijn
This paper explores whether lobbies slow down technology diffusion. To answer this question, we exploit the differential effect of various institutional attributes that should affect the costs of erecting barriers when the new technology has a technologically close... View Details
Comin, Diego, and Bart Hobijn. "Lobbies and Technology Diffusion." Review of Economics and Statistics 91, no. 2 (May 2009): 229–244.
- 16 Jan 2019
- News
Employers Are Clueless When It Comes To Family Caregiving
- May 2017
- Teaching Note
Partners Group: Ain't No Mountain High Enough
Partners Group (PG), a Swiss-based PE manager, initiated a series of strategic shifts and evolved from a predominately fund-of-funds manager into a large, multi-asset class PE firm focused on direct investments. PG was the first PE firm to go public in 2006. A number... View Details
- April 1981 (Revised January 1987)
- Case
Atlantic Aviation Corp.: Westwind Division
Raises issues on monitoring and controlling flight demonstration costs for the Westwind business jet. Atlantic's marketing vice president is concerned about rising demonstration costs, but doesn't wish to deny solid prospects an evaluation ride. He asks the general... View Details
Bonoma, Thomas V. "Atlantic Aviation Corp.: Westwind Division." Harvard Business School Case 581-142, April 1981. (Revised January 1987.)
- February 2016 (Revised February 2017)
- Case
Alvogen
By: Daniel Isenberg and William Kerr
Alvogen is a young Icelandic generic pharmaceutical company, whose CEO believes that his global strategy will give them an edge in this competitive industry.
Robert Wessman, Alvogen’s CEO, was also previously the CEO of Actavis, another Icelandic generics... View Details
Robert Wessman, Alvogen’s CEO, was also previously the CEO of Actavis, another Icelandic generics... View Details
Keywords: Pharmaceutical Companies; Generic Drugs; Entrepreneurship; Globalization; Risk and Uncertainty; Pharmaceutical Industry; Iceland
Isenberg, Daniel, and William Kerr. "Alvogen." Harvard Business School Case 816-064, February 2016. (Revised February 2017.)
- February 1998 (Revised September 1998)
- Case
Insteel Wire Products: ABM at Andrews
By: V.G. Narayanan and Ratna G. Sarkar
Insteel implements an activity-based costing (ABC) system in 1996. It finds pallet nails to be its most profitable product and decides to expand the number of cells making pallet nails from two to four. A repeat of the ABC study in 1997 shows pallet nails have become... View Details
Narayanan, V.G., and Ratna G. Sarkar. "Insteel Wire Products: ABM at Andrews." Harvard Business School Case 198-087, February 1998. (Revised September 1998.)
Trevor Fetter
Trevor Fetter is a Senior Lecturer and the Henry B. Arthur Fellow on the faculty of Harvard Business School. He teaches two MBA required courses: Leadership and Corporate Accountability, and Financial Reporting and Control. At HBS he has also taught a Short... View Details
- September 2002 (Revised July 2012)
- Case
Athleta
By: William A. Sahlman and Taslim Pirmohamed
The management team at Athleta is attempting to raise equity capital for the company in March 2002. Athleta is a catalog and online retailer of women's athletic clothing. The company has made substantial progress, with anticipated 2002 sales over $20 million, but has... View Details
Keywords: Management Teams; Financing and Loans; Business Model; Business Strategy; Equity; Capital; Retail Industry
Sahlman, William A., and Taslim Pirmohamed. "Athleta." Harvard Business School Case 803-045, September 2002. (Revised July 2012.)
- January–February 2019
- Article
Why Some Platforms Thrive and Others Don't
By: Feng Zhu and Marco Iansiti
In the digital economy, scale is no guarantee of continued success. After all, the same factors that help an online platform expand quickly—such as the low cost of adding new customers—work for challengers too. What, then, allows platforms to fight off rivals and grow... View Details
Zhu, Feng, and Marco Iansiti. "Why Some Platforms Thrive and Others Don't." Harvard Business Review 97, no. 1 (January–February 2019): 118–125.
- Article
Undermining Value-Based Purchasing — Lessons from the Pharmaceutical Industry
By: Leemore S. Dafny, Christopher Ody and Matt Schmitt
The analogy between value-based purchasing in pharmaceuticals and the new frontier of alternative payment models for health care providers is relatively straightforward. Insurers are increasingly demanding steep discounts from providers in exchange for inclusion in... View Details
Keywords: Drug Copayment Coupons; Prescription Drug Policy; Health Care and Treatment; Insurance; Cost; Policy; Pharmaceutical Industry
Dafny, Leemore S., Christopher Ody, and Matt Schmitt. "Undermining Value-Based Purchasing — Lessons from the Pharmaceutical Industry." New England Journal of Medicine 375, no. 21 (November 24, 2016): 2013–2015.
- TeachingInterests
Executive Education - Owner/President Management Program
Delivered in three units that span 24 months over three calendar years, the Owner/President Management (OPM) program is a transformative learning experience that boosts leadership skills and the value of participants’ enterprises. Sinozich teaches the Finance... View Details
- March 1999 (Revised October 2002)
- Case
Xerox: Book-In-Time
Book-In-Time, developed at Xerox, can dramatically reduce the cost of printing "one" book. Combined with the possibilities of digital content storage and transmittal, the new technology has vast opportunities. Xerox needs a commercial plan. The case describes the state... View Details
Keywords: Cost Management; Distribution; Planning; Opportunities; Commercialization; Technology Adoption; Publishing Industry
Rangan, V. Kasturi. "Xerox: Book-In-Time." Harvard Business School Case 599-119, March 1999. (Revised October 2002.)